Zoster Vaccines; Risk of Guillain-Barré syndrome (GBS) following recombinant zoster vaccine(RZV); RZV risk-benefit analysis; Work group interpretation; Introduction of the Evidence to Recommendations Framework for use of RZV in immunocompromised adults.

Influenza Vaccines; Influenza surveillance update; Workgroup considerations

Comments on this video are allowed in accordance with our comment policy:


This video can also be viewed at